Adhesion Barrier Market

The global adhesion barrier market size is projected to reach USD 1.11 billion by 2031 from USD 0.78 billion in 2026, at a CAGR of 7.3% during the forecast period.

The increasing volume of surgeries and sports-related injuries, a rising geriatric population, and growing awareness of adhesion formation and adhesion-related diseases are key factors driving growth in the adhesion barrier market. However, reluctance among surgeons toward the routine use of adhesion barriers is expected to restrain market growth during the forecast period. Meanwhile, untapped emerging markets, supported by improving healthcare access and rising surgical volumes, are expected to offer lucrative opportunities for companies operating in the adhesion barrier market.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in the global adhesion barrier market include Baxter (US), Johnson & Johnson (J&J) (US), Medtronic (Ireland), Integra LifeSciences (US), Anika Therapeutics (US), and FzioMed (US). Key players in the adhesion barrier market have adopted a mix of organic and inorganic growth strategies—such as product launches, acquisitions, collaborations, partnerships, agreements, and expansions—to enhance their global presence and increase market share. These initiatives have enabled them to expand geographically and deliver advanced adhesion barrier products across diverse regions.

• In November 2025, Fziomed, Inc. (US) announced the initiation of commercialization of Oxiplex gel in the United States, indicated for reducing postoperative leg pain and neurological symptoms in adult patients undergoing lumbar spine procedures.
• In July 2022, WOMED (France) received ANVISA approval for the Womed Leaf Resorbable Adhesion Barrier, intended to prevent or reduce the formation of new or recurrent intrauterine adhesions by creating a temporary mechanical barrier.

Baxter (US)

Baxter is a well-established player in the adhesion barriers market, with a portfolio comprising Seprafilm, ADEPT, and COSEAL adhesion prevention products. These products are used across key surgical applications, including laparoscopic, gynecological, and general/abdominal surgeries. In February 2020, Baxter completed the acquisition of the Seprafilm Adhesion Barrier product rights from Sanofi, strengthening its position in the biosurgery and adhesion prevention market. Baxter’s strong market presence, established hospital customer base, and global sales network across nearly 100 countries support its continued growth in the adhesion barriers market. The company generates a significant share of its revenue from developed markets, particularly North America and Europe.

Johnson & Johnson (US)

Johnson & Johnson (J&J) is a major player in the market for adhesion barriers owing to its extensive global distribution network spanning North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, as well as more than 250 subsidiaries. One of the most popular brands for gynecological surgeries worldwide is the company's product, GYNECARE INTERCEDE. The company’s continued investment in R&D and inorganic growth further supports its ability to enhance existing products and introduce advanced surgical technologies, positioning it well in the adhesion barrier market.

Medtronic (Ireland)

Medtronic plc is one of the world’s leading medical technology, services, and solutions companies. Established in 1949 and headquartered in Dublin, Ireland, the company serves healthcare providers in over 150 countries across key specialties such as cardiovascular care, neuroscience, medical surgical technologies, and diabetes management. In the adhesion barrier market, Medtronic is represented through its MediShield Anti-Adhesion Gel, which is used in spine and orthopedic procedures to help reduce post-surgical adhesions and support improved surgical outcomes. Backed by its strong global distribution network, established relationships with hospitals, and broad portfolio of surgical technologies, Medtronic is well-positioned to support the adoption of advanced adhesion-prevention products across surgical settings.

MARKET RANKING

The adhesion barrier market is moderately consolidated, with leading players accounting for a significant share of the overall market. Baxter (US) is one of the key players, supported by its established adhesion-prevention portfolio comprising Seprafilm, ADEPT, and COSEAL, as well as its strong hospital presence and global distribution network. Johnson & Johnson (US) also holds a notable position in the market through its Gynecare Interceed product, primarily used in gynecological surgeries. Other prominent companies include Medtronic (Ireland), Integra LifeSciences Corporation (US), and Anika Therapeutics, Inc. (US), which have strengthened their presence through specialty surgical products and established commercial reach. The remaining market is fragmented among regional and emerging players offering film-, gel-, and liquid-based adhesion barriers. Competitive dynamics in this space are shaped by rising surgical volumes, increasing focus on reducing post-surgical complications, growing demand for minimally invasive procedures, and product innovation across specialty-specific surgical applications.

Related Reports:

Adhesion Barrier Market by Product [Synthetic (Hyaluronic Acid, Polyethylene Glycol), Natural], Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery), End User (Hospitals & Clinics) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]